In Brief: Arrow International
This article was originally published in The Gray Sheet
Arrow International: Will initiate full-scale launch of its Trio/Ensemble mapping catheter system in March following limited roll-out of the device in February. Developed by Cardiac Pathways under a strategic partnership between the two companies, the system "enables electrophysiologists to insert up to three mapping catheters through a single introducer," Arrow says. Also available in Europe, the Trio/Ensemble received FDA 510(k) clearance in November...
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.